These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6770411)

  • 1. MDA and DOM: substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat.
    Shannon HE
    Psychopharmacology (Berl); 1980; 67(3):311-2. PubMed ID: 6770411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further investigation of the discriminative stimulus properties of MDA.
    Glennon RA; Young R
    Pharmacol Biochem Behav; 1984 Apr; 20(4):501-5. PubMed ID: 6728867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
    Silverman PB; Ho BT
    Psychopharmacology (Berl); 1980; 68(3):209-15. PubMed ID: 6771804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R; Nichols DE
    Psychopharmacology (Berl); 1988; 95(1):71-6. PubMed ID: 2898791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE; Taylor MM
    Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
    Glennon RA; Young R; Soine W
    Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of MDA analogs.
    Glennon RA; Young R; Rosecrans JA; Anderson GM
    Biol Psychiatry; 1982 Jul; 17(7):807-14. PubMed ID: 6126227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDA: a psychoactive agent with dual stimulus effects.
    Glennon RA; Young R
    Life Sci; 1984 Jan; 34(4):379-83. PubMed ID: 6694526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat.
    Tilson HA; Baker TG; Gylys JA
    Psychopharmacologia; 1975 Nov; 44(3):225-8. PubMed ID: 1208758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
    Winter JC
    Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.
    Glennon RA; Yousif M; Patrick G
    Pharmacol Biochem Behav; 1988 Mar; 29(3):443-9. PubMed ID: 2896360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA).
    Broadbent J; Appel JB; Michael EK; Ricker JH
    Behav Pharmacol; 1992 Oct; 3(5):443-454. PubMed ID: 11224147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
    Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.
    Rangisetty JB; Bondarev ML; Chang-Fong J; Young R; Glennon RA
    Pharmacol Biochem Behav; 2001; 69(1-2):261-7. PubMed ID: 11420094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
    Glennon RA; Misenheimer BR
    Pharmacol Biochem Behav; 1989 Aug; 33(4):909-12. PubMed ID: 2575759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.